Latest news
Loading news…
Zystor
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Milwaukee, Wisconsin, United States Founded 2004 1001-5000 employees For Profit
ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal
Zystor was acquired by BioMarin Pharmaceutical in 2010 for $115M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 6
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- a61
Company Info
- Founded
- 2004
- Employees
- 1001-5000
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- HQ
- Milwaukee, Wisconsin, United States
- Region
- Great Lakes, Midwestern US
- Exit date
- Aug 17, 2010
- Closed
- Nov 28, 2012
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.3
- Trend (90d)
- -0.4
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Zystor
Loading news…
FAQs about Zystor
People who checked this page also checked these
Browse the full Acquirezy directory.